523 related articles for article (PubMed ID: 18519800)
21. Mixed Meal and Intravenous L-Arginine Tests Both Stimulate Incretin Release Across Glucose Tolerance in Man: Lack of Correlation with β Cell Function.
Ruetten H; Gebauer M; Raymond RH; Calle RA; Cobelli C; Ghosh A; Robertson RP; Shankar SS; Staten MA; Stefanovski D; Vella A; Wright K; Fryburg DA;
Metab Syndr Relat Disord; 2018 Oct; 16(8):406-415. PubMed ID: 30117761
[TBL] [Abstract][Full Text] [Related]
22. Pax6 and Pdx1 are required for production of glucose-dependent insulinotropic polypeptide in proglucagon-expressing L cells.
Fujita Y; Chui JW; King DS; Zhang T; Seufert J; Pownall S; Cheung AT; Kieffer TJ
Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E648-57. PubMed ID: 18593849
[TBL] [Abstract][Full Text] [Related]
23. The fatty acid receptor GPR40 plays a role in insulin secretion in vivo after high-fat feeding.
Kebede M; Alquier T; Latour MG; Semache M; Tremblay C; Poitout V
Diabetes; 2008 Sep; 57(9):2432-7. PubMed ID: 18559658
[TBL] [Abstract][Full Text] [Related]
24. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.
Theodorakis MJ; Carlson O; Michopoulos S; Doyle ME; Juhaszova M; Petraki K; Egan JM
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E550-9. PubMed ID: 16219666
[TBL] [Abstract][Full Text] [Related]
25. Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats.
Gowda N; Dandu A; Singh J; Biswas S; Raghav V; Lakshmi MN; Shilpa PC; Sunil V; Reddy A; Sadasivuni M; Aparna K; Verma MK; Moolemath Y; Anup MO; Venkataranganna MV; Somesh BP; Jagannath MR
BMC Pharmacol Toxicol; 2013 May; 14():28. PubMed ID: 23692921
[TBL] [Abstract][Full Text] [Related]
26. Lipid receptors and islet function: therapeutic implications?
Kebede MA; Alquier T; Latour MG; Poitout V
Diabetes Obes Metab; 2009 Nov; 11 Suppl 4(Suppl 4):10-20. PubMed ID: 19817784
[TBL] [Abstract][Full Text] [Related]
27. Yhhu4488, a novel GPR40 agonist, promotes GLP-1 secretion and exerts anti-diabetic effect in rodent models.
Guo DY; Li DW; Ning MM; Dang XY; Zhang LN; Zeng LM; Hu YH; Leng Y
Biochem Biophys Res Commun; 2015 Oct; 466(4):740-7. PubMed ID: 26417688
[TBL] [Abstract][Full Text] [Related]
28. Free fatty acid receptor GPR120 is highly expressed in enteroendocrine K cells of the upper small intestine and has a critical role in GIP secretion after fat ingestion.
Iwasaki K; Harada N; Sasaki K; Yamane S; Iida K; Suzuki K; Hamasaki A; Nasteska D; Shibue K; Joo E; Harada T; Hashimoto T; Asakawa Y; Hirasawa A; Inagaki N
Endocrinology; 2015 Mar; 156(3):837-46. PubMed ID: 25535828
[TBL] [Abstract][Full Text] [Related]
29. Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion.
Fujita Y; Wideman RD; Asadi A; Yang GK; Baker R; Webber T; Zhang T; Wang R; Ao Z; Warnock GL; Kwok YN; Kieffer TJ
Gastroenterology; 2010 May; 138(5):1966-75. PubMed ID: 20138041
[TBL] [Abstract][Full Text] [Related]
30. The Effect of Melatonin on Incretin Hormones: Results From Experimental and Randomized Clinical Studies.
Lauritzen ES; Støy J; Bæch-Laursen C; Grarup N; Jessen N; Hansen T; Møller N; Hartmann B; Holst JJ; Kampmann U
J Clin Endocrinol Metab; 2021 Nov; 106(12):e5109-e5123. PubMed ID: 34265066
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of GPR40 in pancreatic beta-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice.
Nagasumi K; Esaki R; Iwachidow K; Yasuhara Y; Ogi K; Tanaka H; Nakata M; Yano T; Shimakawa K; Taketomi S; Takeuchi K; Odaka H; Kaisho Y
Diabetes; 2009 May; 58(5):1067-76. PubMed ID: 19401434
[TBL] [Abstract][Full Text] [Related]
32. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
[TBL] [Abstract][Full Text] [Related]
33. Incretin concept revised: The origin of the insulinotropic function of glucagon-like peptide-1 - the gut, the islets or both?
Yabe D; Seino Y; Seino Y
J Diabetes Investig; 2018 Jan; 9(1):21-24. PubMed ID: 28746743
[TBL] [Abstract][Full Text] [Related]
34. Gustducin couples fatty acid receptors to GLP-1 release in colon.
Li Y; Kokrashvili Z; Mosinger B; Margolskee RF
Am J Physiol Endocrinol Metab; 2013 Mar; 304(6):E651-60. PubMed ID: 23341498
[TBL] [Abstract][Full Text] [Related]
35. Physiology and therapeutics of the free fatty acid receptor GPR40.
Huang H; Dai MH; Tao YX
Prog Mol Biol Transl Sci; 2014; 121():67-94. PubMed ID: 24373235
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of incretin secretion by dietary lipid: is it dose dependent?
Yoder SM; Yang Q; Kindel TL; Tso P
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G299-305. PubMed ID: 19520739
[TBL] [Abstract][Full Text] [Related]
37. Bile acids are important direct and indirect regulators of the secretion of appetite- and metabolism-regulating hormones from the gut and pancreas.
Kuhre RE; Wewer Albrechtsen NJ; Larsen O; Jepsen SL; Balk-Møller E; Andersen DB; Deacon CF; Schoonjans K; Reimann F; Gribble FM; Albrechtsen R; Hartmann B; Rosenkilde MM; Holst JJ
Mol Metab; 2018 May; 11():84-95. PubMed ID: 29656109
[TBL] [Abstract][Full Text] [Related]
38. Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans.
Christensen MB
Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034187
[TBL] [Abstract][Full Text] [Related]
39. Insulin is secreted upon glucose stimulation by both gastrointestinal enteroendocrine K-cells and L-cells engineered with the preproinsulin gene.
Encina G; Ezquer F; Conget P; Israel Y
Biol Res; 2011; 44(3):301-5. PubMed ID: 22688918
[TBL] [Abstract][Full Text] [Related]
40. Long-term in vitro treatment of INS-1 rat pancreatic β-cells by unsaturated free fatty acids protects cells against gluco- and lipotoxicities via activation of GPR40 receptors.
Tuo Y; Feng DD; Wang DF; Sun J; Li SB; Chen C
Clin Exp Pharmacol Physiol; 2012 May; 39(5):423-8. PubMed ID: 22332921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
